EVIDENCE FOR PITUITARY ADENYLATE-CYCLASE ACTIVATING POLYPEPTIDE (PACAP) AND PACAP1 RECEPTOR IN HUMAN SKIN - PACAP-38 IS INCREASED IN PSORIASIS PATIENTS
M. Steinhoff et al., EVIDENCE FOR PITUITARY ADENYLATE-CYCLASE ACTIVATING POLYPEPTIDE (PACAP) AND PACAP1 RECEPTOR IN HUMAN SKIN - PACAP-38 IS INCREASED IN PSORIASIS PATIENTS, Journal of investigative dermatology, 109(3), 1997, pp. 408-408